Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis C | 8 | 2022 | 1591 | 2.290 |
Why?
|
| Tissue and Organ Procurement | 5 | 2023 | 896 | 1.470 |
Why?
|
| Lung Transplantation | 4 | 2019 | 1155 | 1.450 |
Why?
|
| Heart Transplantation | 5 | 2023 | 3113 | 1.200 |
Why?
|
| Hepatitis C, Chronic | 3 | 2022 | 1029 | 1.010 |
Why?
|
| Hepacivirus | 4 | 2022 | 1378 | 0.970 |
Why?
|
| Tissue Donors | 13 | 2023 | 2241 | 0.970 |
Why?
|
| Organ Transplantation | 4 | 2023 | 1140 | 0.960 |
Why?
|
| Endocarditis | 2 | 2024 | 349 | 0.860 |
Why?
|
| Heart Injuries | 1 | 2021 | 210 | 0.710 |
Why?
|
| Endocarditis, Bacterial | 1 | 2023 | 455 | 0.690 |
Why?
|
| Carbamates | 1 | 2019 | 196 | 0.600 |
Why?
|
| Babesia microti | 1 | 2017 | 31 | 0.580 |
Why?
|
| Antiviral Agents | 4 | 2022 | 2984 | 0.540 |
Why?
|
| Babesiosis | 1 | 2017 | 92 | 0.540 |
Why?
|
| Splenectomy | 1 | 2017 | 394 | 0.520 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2017 | 142 | 0.520 |
Why?
|
| Cardiology | 1 | 2023 | 1668 | 0.420 |
Why?
|
| Heart-Assist Devices | 1 | 2019 | 1195 | 0.330 |
Why?
|
| Heart Failure | 3 | 2023 | 10896 | 0.330 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3134 | 0.310 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3241 | 0.310 |
Why?
|
| Pandemics | 7 | 2022 | 8385 | 0.250 |
Why?
|
| Cardiovascular Infections | 1 | 2024 | 5 | 0.250 |
Why?
|
| Antibodies, Neutralizing | 3 | 2021 | 1978 | 0.220 |
Why?
|
| Burkholderia cepacia | 1 | 2022 | 22 | 0.220 |
Why?
|
| Burkholderia cepacia complex | 1 | 2022 | 25 | 0.220 |
Why?
|
| Burkholderia Infections | 1 | 2022 | 44 | 0.210 |
Why?
|
| Antibodies, Viral | 6 | 2023 | 3175 | 0.200 |
Why?
|
| RNA, Viral | 2 | 2020 | 2901 | 0.190 |
Why?
|
| Humans | 43 | 2024 | 743811 | 0.190 |
Why?
|
| Ritonavir | 1 | 2022 | 322 | 0.190 |
Why?
|
| Nucleic Acids | 1 | 2023 | 182 | 0.180 |
Why?
|
| Transplants | 1 | 2022 | 209 | 0.180 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 5136 | 0.180 |
Why?
|
| Neutralization Tests | 1 | 2021 | 757 | 0.170 |
Why?
|
| BK Virus | 1 | 2020 | 129 | 0.170 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2020 | 225 | 0.170 |
Why?
|
| Hepatitis C Antibodies | 1 | 2019 | 145 | 0.170 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2022 | 289 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2023 | 638 | 0.160 |
Why?
|
| Paraganglioma | 1 | 2019 | 143 | 0.150 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2018 | 249 | 0.150 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2022 | 555 | 0.150 |
Why?
|
| Heparin | 2 | 2021 | 1637 | 0.140 |
Why?
|
| Troponin T | 1 | 2021 | 754 | 0.140 |
Why?
|
| Graft Rejection | 2 | 2020 | 4398 | 0.140 |
Why?
|
| Viremia | 1 | 2019 | 736 | 0.140 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2022 | 1683 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2019 | 8316 | 0.140 |
Why?
|
| Heart Neoplasms | 1 | 2019 | 374 | 0.130 |
Why?
|
| Standard of Care | 1 | 2019 | 564 | 0.130 |
Why?
|
| Intensive Care Units | 4 | 2022 | 3679 | 0.130 |
Why?
|
| Consensus | 2 | 2024 | 2954 | 0.130 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2024 | 2016 | 0.130 |
Why?
|
| Cross Infection | 1 | 2022 | 1416 | 0.110 |
Why?
|
| Cytomegalovirus | 1 | 2017 | 733 | 0.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 1354 | 0.100 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2021 | 363 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 1240 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 5445 | 0.090 |
Why?
|
| Cytomegalovirus Infections | 1 | 2017 | 820 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 1911 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 5388 | 0.090 |
Why?
|
| Heart | 1 | 2023 | 4460 | 0.090 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2018 | 1052 | 0.090 |
Why?
|
| Adult | 12 | 2022 | 213889 | 0.080 |
Why?
|
| Thrombosis | 1 | 2022 | 2968 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2017 | 2037 | 0.080 |
Why?
|
| Graft Survival | 1 | 2019 | 3734 | 0.080 |
Why?
|
| Sepsis | 1 | 2022 | 2593 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2018 | 1970 | 0.080 |
Why?
|
| Decision Trees | 1 | 2020 | 506 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4665 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 2375 | 0.080 |
Why?
|
| Immunoglobulin A | 2 | 2021 | 995 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2022 | 40545 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2019 | 3817 | 0.070 |
Why?
|
| United States | 3 | 2023 | 69859 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2018 | 2945 | 0.070 |
Why?
|
| Middle Aged | 9 | 2022 | 213241 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7172 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2022 | 63042 | 0.070 |
Why?
|
| Hospitalization | 2 | 2022 | 10259 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 13691 | 0.060 |
Why?
|
| Male | 10 | 2022 | 349776 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2022 | 53250 | 0.060 |
Why?
|
| Nucleocapsid | 1 | 2023 | 59 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 6485 | 0.050 |
Why?
|
| Community Health Centers | 1 | 2006 | 428 | 0.050 |
Why?
|
| Female | 12 | 2022 | 380020 | 0.050 |
Why?
|
| Age Factors | 1 | 2019 | 18355 | 0.050 |
Why?
|
| Ammonia | 1 | 2022 | 239 | 0.050 |
Why?
|
| Drug Contamination | 1 | 2022 | 147 | 0.050 |
Why?
|
| Blood Donors | 1 | 2023 | 355 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 11708 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2023 | 401 | 0.050 |
Why?
|
| Aged | 7 | 2022 | 163178 | 0.050 |
Why?
|
| Intubation | 1 | 2020 | 141 | 0.050 |
Why?
|
| Prothrombin Time | 1 | 2020 | 119 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2006 | 685 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 128 | 0.050 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2021 | 421 | 0.040 |
Why?
|
| Protein Structure, Quaternary | 1 | 2021 | 436 | 0.040 |
Why?
|
| Respiratory Therapy | 1 | 2020 | 132 | 0.040 |
Why?
|
| Partial Thromboplastin Time | 1 | 2020 | 206 | 0.040 |
Why?
|
| Organ Preservation | 1 | 2022 | 331 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2020 | 424 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 1 | 2021 | 517 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2021 | 4561 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 1108 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2023 | 775 | 0.040 |
Why?
|
| Pneumocystis carinii | 1 | 2018 | 74 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.040 |
Why?
|
| Enoxaparin | 1 | 2020 | 377 | 0.040 |
Why?
|
| Immunoassay | 1 | 2021 | 751 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2021 | 576 | 0.040 |
Why?
|
| Urban Population | 1 | 2006 | 2021 | 0.040 |
Why?
|
| Ferritins | 1 | 2020 | 590 | 0.040 |
Why?
|
| American Heart Association | 1 | 2022 | 1057 | 0.040 |
Why?
|
| Carrier State | 1 | 2021 | 518 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2020 | 894 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 1537 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 2022 | 1572 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 1622 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 2011 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15142 | 0.030 |
Why?
|
| Water | 1 | 2022 | 1394 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2021 | 971 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 14714 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 612 | 0.030 |
Why?
|
| Anticoagulants | 2 | 2021 | 4599 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2006 | 2683 | 0.030 |
Why?
|
| Mothers | 1 | 2006 | 2166 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2024 | 20121 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1013 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2617 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 2123 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3874 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1781 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3268 | 0.030 |
Why?
|
| Young Adult | 4 | 2022 | 56392 | 0.030 |
Why?
|
| Risk Factors | 2 | 2018 | 72252 | 0.030 |
Why?
|
| Adenine | 1 | 2018 | 935 | 0.030 |
Why?
|
| Heart Atria | 1 | 2019 | 1357 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 1771 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2009 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4749 | 0.030 |
Why?
|
| Incidence | 2 | 2022 | 20948 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15526 | 0.030 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 689 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5078 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 57744 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 3921 | 0.020 |
Why?
|
| Piperidines | 1 | 2018 | 1601 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3275 | 0.020 |
Why?
|
| Critical Illness | 1 | 2022 | 2670 | 0.020 |
Why?
|
| Algorithms | 1 | 2020 | 13869 | 0.020 |
Why?
|
| Adolescent | 3 | 2022 | 85729 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3778 | 0.020 |
Why?
|
| Health Personnel | 1 | 2022 | 3217 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1520 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2022 | 5316 | 0.020 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 1670 | 0.020 |
Why?
|
| Boston | 1 | 2020 | 9310 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4386 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2020 | 5986 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 6237 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4477 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12020 | 0.020 |
Why?
|
| Registries | 1 | 2022 | 8090 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 7908 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9440 | 0.020 |
Why?
|
| Lung | 1 | 2023 | 9858 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 3537 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9272 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13273 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21733 | 0.010 |
Why?
|
| Kenya | 1 | 2006 | 685 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2022 | 77410 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2021 | 40964 | 0.010 |
Why?
|
| Culture | 1 | 2006 | 632 | 0.010 |
Why?
|
| Focus Groups | 1 | 2006 | 1320 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 25609 | 0.010 |
Why?
|
| Professional-Patient Relations | 1 | 2006 | 737 | 0.010 |
Why?
|
| HIV Infections | 1 | 2006 | 16715 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 35122 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2006 | 2453 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2006 | 2232 | 0.010 |
Why?
|
| Child | 1 | 2021 | 77637 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 7784 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2006 | 4255 | 0.010 |
Why?
|
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(154)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_